🇨🇭 Swiss Precision & Compliance

Large Biopharma Clinical Trial Software

Clinical trial software for
large biopharma companies

oomnia centralizes EDC, CTMS, eTMF, RTSM, and patient-facing tools within one clinical research information system (CRIS), enabling biopharma teams to reduce complexity and oversee global studies with greater accuracy and speed.

Book a Demo Explore oomnia
21 CFR Part 11 ICH-GCP GDPR GxP-aligned

Industry Challenges

Industry challenges large biopharma companies face

Large biopharma organizations run complex, multi-regional trial portfolios with dozens of systems, CROs, and global sites. The scale introduces operational and compliance challenges that smaller setups rarely encounter.

  1. Fragmented eClinical ecosystems across vendors and partners, limiting visibility and control

  2. Managing large, multi-study portfolios across regions and therapeutic areas

  3. Difficulty maintaining standardized processes and governance across global trial sites and CROs

  4. Inconsistent data standards across CROs and systems requiring constant reconciliation

  5. Manual data reconciliation between systems delays decisions and increases operational risk

  6. Scaling studies across countries and sites is challenging without unified, cloud-native systems

  7. Fragmented audit trails and incomplete traceability across systems reduce inspection readiness

Our Solution

Wemedoo's clinical trial solution for large biopharma companies

oomnia provides a unified platform designed for large biopharma operations:

One unified system for trial execution

All study modules run inside a single, connected CRIS environment.

Real-time study visibility and control

Sponsors get instant visibility into sites, subjects, data, and documentation.

Standardized processes across studies

Reusable templates and automated workflows shorten setup timelines.

Integrated regulatory compliance

Built-in audit trails, e-signatures, and validation-ready workflows.

The Platform

Clinical trial capabilities across your portfolio

ECONSENT

eConsent software

Electronic informed consent solution for compliant participant onboarding

EPRO

ePRO software

Real‑time electronic patient‑reported outcomes solution

RTSM

RTSM software

Randomization and Trial Supply Management system that automates allocation workflows and ensures consistent blinding

CTMS

CTMS software

Centralized trial management solution designed to streamline study oversight

EDC

EDC software

Unified Electronic Data Capture built for secure, real-time clinical insights

ETMF

eTMF software

Structured workspace for storing, managing, and accessing trial master file documents

ECOA

eCOA software

Real-time and digital outcome assessments across patients and clinicians

ESOURCE

eSource clinical trials

Electronic source system designed for real‑time, fully validated site data, without the need for manual transcription

Why It Matters

Why unified clinical trial software matters for large biopharma companies

Many large biopharma companies still rely on disconnected, standalone systems and multiple vendors, creating operational complexity and limiting visibility across studies.

A unified clinical trial platform, built as a Clinical Research Information System (CRIS), addresses these challenges by connecting all study functions within a single environment.

This enables consistent data flow, improved global oversight, and more efficient execution of complex, multi-country clinical trials.

Modular eClinical Systems

Data spread across multiple tools and vendors

High manual reconciliation effort

Fragmented audit trails across systems

Slower due to system fragmentation

Unified Clinical Trial Software (oomnia)

Data flows within one system in real time

Reduced reconciliation through shared data model

One unified audit trail

Faster study execution and decision-making

SIDE BY SIDE

Modular eClinical system vs. Unified clinical trial software

Modular eClinical system vs. Unified clinical trial software
Area Modular eClinical system Unified clinical trial software (oomnia)
Data flow Data spreads across multiple tools and vendors Data flows within one system in real time
Reconciliation High manual reconciliation effort Reduced reconciliation through shared data model
Risk of errors Increased due to inconsistencies Reduced through structured and unified data
Team workload Time spent aligning data across systems More time for analysis and oversight
Patient safety Delayed visibility into safety signals Faster access to safety-related data
Regulatory readiness Harder to maintain ALCOA+ standards Easier traceability and inspection readiness
Operational speed Slower due to system fragmentation Faster study execution and decision-making

Regulatory Readiness

Compliance and regulatory readiness

The oomnia clinical trial software is built to support regulated clinical research environments, helping biopharma teams maintain compliance, streamline documentation, and stay inspection-ready through every phase of the trial:

Aligned with GxP principles

Supports GxP-aligned processes across all clinical research operations

Supports compliance with 21 CFR Part 11

Fully compatible with 21 CFR Part 11 electronic records and signature requirements

ICH-GCP-compliant workflows and oversight controls

Workflows structured in accordance with ICH-GCP standards and oversight principles

GDPR-aligned data handling and privacy safeguards

GDPR-compliant data handling and privacy protection across all study environments

Built-in audit trails and full data traceability

Automatic audit trails and complete data traceability across all study operations

Validation documentation and continuous system compliance support

Clear validation documentation and ongoing support to keep the system compliant

Why compliance risk increases in modular eClinical setups

Get Started

Scale global clinical trials with full oversight

See how a unified clinical trial platform can support complex study portfolios, improve data consistency, and enable real-time visibility across global operations.

Talk to our team

Frequently asked questions

What is clinical trial software for large biopharma companies?

Clinical trial software for large biopharma companies is a unified clinical research information system (CRIS) that replaces multiple standalone systems with one connected environment. By consolidating study operations across regions and functional teams, it helps reduce data silos, eliminate redundant processes, and maintain consistent oversight.

How does oomnia help large biopharma teams manage complex, multi‑country studies?

oomnia centralizes all study modules within a single clinical research information system (CRIS), enabling sponsors and CROs to coordinate countries, sites, subjects, documents, and workflows across global operations. This unified environment supports cross‑regional collaboration, accelerates study startup, and minimizes delays caused by disconnected systems, crucial for large biopharma organizations conducting high‑volume, geographically dispersed trials.

How does oomnia support regulatory compliance for large biopharma companies?

oomnia is designed to align with international biopharma regulatory standards, including GxP, 21 CFR Part 11, ICH‑GCP, GDPR, and other region‑specific data‑privacy and clinical compliance requirements. Built‑in audit trails, role‑based permissions, validated e‑signatures, and comprehensive documentation help ensure inspection readiness for global health authorities throughout the trial lifecycle.

Can oomnia replace multiple clinical trial systems used by large biopharma organizations?

Yes. oomnia unifies EDC, CTMS, eTMF, RTSM, ePRO/eCOA, eConsent, and eSource into a unified clinical trial software. This reduces the complexity and cost of managing large technology stacks, an issue commonly faced by large biopharma teams operating across continents, therapeutic areas, and vendor ecosystems.

How does unified software reduce manual data reconciliation in large‑scale studies?

Since all modules operate on a shared data model within one CRIS, information is automatically synchronized across functional areas. This eliminates cross‑system data transfers, manual imports/exports, reconciliation spreadsheets, and duplicative quality checks, significantly accelerating workflows in high‑volume studies with large datasets and frequent updates.

Can oomnia integrate with external systems used by large biopharma companies?

Because oomnia uses a unified data architecture, many workflows no longer require external system integrations. However, when integrations are needed, for example, enterprise data lakes, safety systems, or global regulatory platforms, oomnia can exchange data while maintaining complete operational traceability within the CRIS environment.

Does oomnia improve global visibility for clinical operations and study leadership?

Yes. Real‑time dashboards provide global sponsors, CRO partners, and study leadership with continuous visibility into site performance, enrollment progress, patient status, deviations, milestones, document timelines, and operational KPIs across all regions. This eliminates dependence on manual reporting and ensures timely decision‑making for complex, multinational trial portfolios.

Ready to streamline your Biopharma studies?

Request a Demo Contact Us